Battery Ventures Backs Vetspire’s Veterinary AI Platform

Vetspire, the cloud-based operating system for veterinary practices, has received a significant growth investment from Battery Ventures. The transaction was announced on August 13, 2026, and financial terms, valuation, and ownership details were not disclosed.

The investment places fresh capital and a new CEO behind a platform that combines medical records, scheduling, billing, inventory, client communications, reporting, and AI-assisted clinical workflows. Zachary Seely joins Vetspire as CEO, Joseph Mazzarella continues as President, and Battery General Partner Chelsea Stoner is the named investor executive in the announcement.

The broader implication sits beyond veterinary software. Battery is backing a vertical system of record that aims to serve both large multi-site operators and independent clinics, a market where the winning platform must carry administrative scale without getting in the way of clinical work.

What Battery Ventures Is Backing

Battery's announcement describes its commitment as a significant growth investment rather than a numbered funding round. That distinction matters because no Series A, Series B, or other round label was disclosed, and no official source reviewed for this article supplied an amount, valuation, ownership percentage, or additional investor syndicate.

Vetspire is a practice information management system, commonly called a PIMS, designed around clinical workflows. The platform brings medical records, scheduling, billing, inventory, pricing, client communications, treatment workflows, and reporting into one cloud-based product, then layers AI-assisted documentation and patient summaries into the working environment rather than selling them as disconnected tools.

The company serves a wide customer range, from independent veterinary clinics to enterprise groups managing multiple locations. Battery says the opportunity is to grow Vetspire as a forward-looking, independent technology provider for that entire market, which makes product neutrality and interoperability as important as feature depth.

Why Veterinary Practices Need Better Infrastructure

Veterinary medicine has an attention problem disguised as a software problem. Clinicians and support teams need accurate records, coordinated schedules, clean billing, inventory control, client communication, and reliable handoffs, but every additional system creates another place to log in, another record to reconcile, and another task competing with patient care.

Vetspire's answer is to make the practice platform carry more of that operational load. Its medical-record workflow supports real-time documentation and multi-user editing, while its scheduling, communications, pricing, reporting, and specialty modules are designed to keep clinical and administrative data in the same operating environment.

The company has also pushed AI directly into documentation. Vetspire says its AI Suite can save clinicians up to 90 minutes per day, and company-reported research with INSIGHT2PROFIT found that 58% of respondents considered AI Scribe a must-have feature and 33% said the same about AI Summary. Those figures are not independent performance guarantees, but they show where Vetspire believes buyers feel the greatest pressure: documentation time, cognitive load, and the work that follows clinicians home.

A Leadership Change Built for the Next Stage

Zachary Seely joins Vetspire as CEO after leading FSI, a software platform serving acute-care hospitals. The move adds an executive with experience scaling specialized software in a complex healthcare setting, where products must satisfy operators, frontline professionals, and the financial realities of facility management at the same time.

Joseph Mazzarella remains with Vetspire as President. His public profile previously identified him as Vetspire CEO and Thrive Pet Healthcare CTO, but the current Battery announcement supersedes that CEO title and places Mazzarella alongside Seely for the company's next stage.

Vetspire's founding story still matters to the product thesis. Sam Ginn cofounded the company and served as CEO from 2018 through 2024 after seeing the burden of veterinary documentation through his mother's work as a veterinarian, turning a personal view of after-hours charting into a platform built around clinical efficiency.

The Pathway and Thrive History

Pathway Vet Alliance acquired Vetspire in April 2021 for undisclosed terms. The official announcement said Vetspire would continue operating independently and serve hospitals both inside and outside the Pathway network, while Pathway planned to invest in product development and new features.

Pathway later became Thrive Pet Healthcare, placing Vetspire inside a broader veterinary-care ecosystem. The August 2026 announcement does not disclose whether Thrive sold all or part of its ownership, retained an interest, or participated in a recapitalization, so any precise description of the post-transaction cap table would outrun the public record.

What can be said is narrower and more useful. Battery is publicly framing Vetspire as an independent technology provider with room to grow across the entire market, suggesting that the company's value depends on serving practices with different ownership models rather than functioning only as software for one veterinary group.

Why the Battery Thesis Fits Vetspire

Battery Ventures has a long record in vertical software, and Chelsea Stoner's portfolio focus includes vertically oriented SaaS and healthcare IT. Vetspire sits at the intersection of those themes: specialized workflow software, sensitive clinical data, fragmented practice operations, and a customer base that needs measurable time savings more than another impressive demo.

The investment also reflects a durable advantage in vertical systems of record. Once a practice relies on one platform for records, scheduling, billing, inventory, communications, and reporting, the software becomes operational infrastructure, but that position creates a higher standard for reliability, interoperability, customer support, and responsible product design.

AI raises the stakes without changing the core test. A clinical assistant is valuable only when it reduces work, keeps clinicians in control, and returns usable information to the correct patient record; otherwise, it is another layer the practice has to manage. Vetspire's opportunity is to make AI feel less like a separate product category and more like a quiet capability inside the workflows teams already trust.

What Comes Next for Vetspire

Vetspire's 2025 product review points to a widening platform, including a Complete AI Suite for Clinical Intelligence, Vetspire Pay, specialty modules for ophthalmology, dentistry, and equine practices, and a patient mobile app. The roadmap shows a company moving from core PIMS functions toward a broader operating layer for different practice types and care settings.

The growth investment gives Vetspire more capacity to pursue that strategy, but the official announcement does not itemize hiring targets, geographic expansion, acquisition plans, or a use-of-proceeds budget. Editors and readers should treat those items as open questions, not fill them with familiar growth-equity assumptions.

The strategic challenge is more concrete. Vetspire must prove that a broader product can remain simple for frontline teams, work across independent and enterprise practices, and turn AI into dependable clinical assistance without compromising clinician judgment. If it succeeds, Battery will have backed more than a veterinary software company; it will have backed the operating infrastructure for a market learning that better technology should return attention to care rather than consume more of it.